VCYT Veracyte Inc
1,124
$21.37
$0.74
(3.59%)
| Watchers | 1,124 |
| 52-Wk Low | $18.61 |
| 52-Wk High | $30.52 |
| Market Cap | $1.63B |
| Volume | 1.05M |
| 52-Wk High | $30.52 |
| 52-Wk Low | $18.61 |
Veracyte Announces First Quarter 2024 Financial ResultsBusiness Wire • 3 days ago
Veracyte, Inc. (Nasdaq: VCYT) today announced financial results for the first quarter ended March 31, 2024. We had a strong start to 2024, driven by robust growth from our market-leading Decipher...
Share to Feed
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that data from 14 presentations at AUA 2024, the annual meeting of the American Urological Association, show that...
Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release financial results for the first quarter of 2024 after the close of market on Tuesday, May 7, 2024. Company management will host a...
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that a new study published in JCO Precision Oncology shows that, among patients undergoing Active Surveillance...
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that nine abstracts focused on its Decipher Prostate and Decipher Bladder Genomic Classifiers will be presented at...
For the last three days, A.I.dvisor has detected that VCYT's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
Veracyte, Inc. (NASDAQ:VCYT Get Free Report) has received an average recommendation of Moderate Buy from the five research firms that are presently covering the stock...
Veracyte, Inc. (NASDAQ:VCYT Get Free Report) has been given a consensus recommendation of Moderate Buy by the five ratings firms that are currently covering the company...
For the last three days, A.I.dvisor has detected that VCYT's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
This is a signal that VCYT's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...